GLAXO — GlaxoSmithKline Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for GlaxoSmithKline Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	10,618	11,372	28,309	16,541	18,568
Net Total Accounts Receivable
Net Total Receivables	1,907	2,975	3,052	3,419	3,720
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	17,749	22,026	37,080	24,943	27,984
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8,271	3,554	3,254	3,151	3,107
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	31,332	31,146	46,333	33,266	35,566
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	10,220	13,546	16,984	13,264	15,249
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	13,126	16,364	19,703	15,853	17,790
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	18,206	14,783	26,630	17,413	17,776
Total Liabilities & Shareholders' Equity	31,332	31,146	46,333	33,266	35,566
Total Common Shares Outstanding